Related Experiment Video
Updated: Jul 9, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Antithrombotic therapy of acute coronary syndromes]
1Medizinische Klinik I, Kardiologie und Angiologie, Medizinische Klinik I, Hochtaunus-Kliniken, Urselerstrasse 33, 61348 Bad Homburg. hans.hoelschermann@hochtaunus-kliniken.de
Insights
Recent advances in acute coronary syndromes (ACS) treatment improve patient outcomes. This review highlights optimal antithrombotic strategies for angioplasty in ACS patients, enhancing early invasive treatment benefits.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Context:
- Acute coronary syndromes (ACS) management has evolved with new guidelines.
- Current non-ST-elevation ACS treatment involves combined antithrombotic therapy.
- This includes aspirin, clopidogrel, and various anticoagulants or glycoprotein IIb/IIIa inhibitors.
Purpose:
- To review and present recommendations for antithrombotic strategies in ACS patients undergoing angioplasty.
- To emphasize appropriate use of combined antithrombotic therapy.
- To align treatment with recent guideline advancements.
Summary:
- Combined antithrombotic therapy, including aspirin, clopidogrel, and anticoagulants (heparins, FXa-inhibitors, direct antithrombins), is recommended for non-ST-elevation ACS.
- Glycoprotein IIb/IIIa receptor antagonists may be used adjunctively.
- This strategy enhances the benefits of early invasive approaches like percutaneous coronary angioplasty with stenting.
Impact:
- Improved patient outcomes in ACS.
- Reduced incidence of major coronary events.
- Optimized use of antithrombotic therapy in interventional cardiology for ACS.
Abstract:
Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome and the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined antithrombotic therapy (including aspirin, clopidogrel, anticoagulation with low-molecular weight or unfractionated heparins or FXa-inhibitors or direct antithrombins and, eventually glycoprotein IIb/IIIa receptor antagonists). This combined antithrombotic therapy allows to increase the benefit of an early invasive strategy including coronary angiogram with stent percutaneous coronary angioplasty. The purpose of this review is to discuss and highlight the recommendations for the appropriate use of antithrombotic strategies in the setting of angioplasty in ACS patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

